A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
Clinical trial NCT03628924 · COMPLETED
Trial details
- NCT number
- NCT03628924
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-04
- Primary completion
- 2020-05-22
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.